ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 746351 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 746351; 2) Community: the network communities that were significantly associated with the response to NSC 746351; 3) Molecule: the relationships between components within communities and NSC 746351; 4) MDR: the compounds that were significantly associated with the NSC 746351.

NSC Compound Enrichment Correlation
NSC 33570 Null 0.0297837393005856 0.31817619
NSC 339579 7H-Pyrrolo[3,2-f]quinazoline-2,4-diamine, 7-[(3-nitrophenyl)methyl]-, monoacetate 0.0297837393005856 0.55311788
NSC 351521 Ethanesulfonic acid, 2-hydroxy-, compd. with 6-[(2,5-dimethoxyphenyl)methyl]-5-methylpyrido[2,3-d] pyrimidine-2,4-diamine (1:1) 0.0297837393005856 0.53098218
NSC 371777 Null 0.0297837393005856 0.32689015
NSC 45236 Null 0.0297837393005856 0.42429923
NSC 55236 Null 0.0297837393005856 0.16821667
NSC 614887 Platinum, (1,2-cyclohexanediamine-N,N')bis (4-morpholinepropanesulfonato-O)-, (SP-4-2) 0.0297837393005856 0.41588428
NSC 638409 (E)N-Ethyl-[3-(4-methoxyphenyl)-2-(3,4,5-trimethoxyphenyl) prop-2-enoamide 0.0297837393005856 0.39879862
NSC 63878 Cytarabine Hydrochloride AZ 0.0297837393005856 0.40548935
NSC 649664 Null 0.0297837393005856 0.25417102
Total:78  Current:49    [First] [Prev] [Next] [Last]